“…From the results shown in Figure S12 , we come to know that with the increase of n (LA): n (IDA), the Pb 2+ chelating capacity of P(LA- co -IDA)s is gradually decreased from 1.80 mg·g −1 of IDA8 to 0.33 mg·g −1 of IDA128. The datum is similar to ( Tahtat et al., 2017 ; El-Ashgar et al., 2017 ) or higher than ( Liu et al., 2020 ; Blicharska et al., 2018 ) that of the reported polymeric (or M w over 1,200 Da) Pb 2+ chelators using IDA or other substances as functional groups. Importantly, this level of chelating capacity is suitable for a potential biomedical chelating agent as a treatment drug for chelating and removing lead ions in vivo because the threshold of lead poisoning that requires treatment is 10 μg·dL −1 ( Balasubramanian et al., 2020 ), and the corresponding dosage of small molecule chelating drugs is as low as 30 mg·kg −1 body weight per day ( Safi et al., 2019 ).…”